Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
ADHXF > SEC Filings for ADHXF > Form 8-K on 20-Jun-2013All Recent SEC Filings

Show all filings for ADHEREX TECHNOLOGIES INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for ADHEREX TECHNOLOGIES INC


20-Jun-2013

Change in Directors or Principal Officers, Submission of Matters to a Vo


Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Effective June 19, 2013, Dr. Thomas Spector resigned as Chief Scientific Officer of the Company, and entered into a Separation and Mutual Release Agreement with the Company, a copy of which is attached hereto as Exhibit 10.23. Dr. Spector will transition to a consultant to Adherex.



Item 5.07 Submission of Matters to a Vote of Security Holders

On June 18, 2013, Adherex Technologies Inc. (the "Company") held an annual meeting of shareholders (the "Meeting"). The shareholders approved all proposals considered at the Meeting and approved all nominees of the Company for director, as follows:

1. The following five (5) nominees were elected to serve as directors, each to serve until the next annual meeting of shareholders of the Company or until their respective successor shall have been duly elected or duly approved:

        Name of Nominee      Votes For        Votes Withheld      Broker Non-Votes
        Robert C. Andrade     25,157,326              535               N/A
        David Lieberman       25,157,326              535               N/A
        Chris Rallis          25,157,326              535               N/A
        Rostislav Raykov      25,157,326              535               N/A
        Steven Skolsky        25,157,326              535               N/A

2. The resolution to re-appoint Deloitte & Touche LLP as independent public accounting firm of the Company and to authorize the Audit Committee of the Board of Directors to fix their remuneration was approved based on the following vote:

                       Votes For                25,157,799
                       Votes Withheld                   62
                       Abstentions                       0
                       Broker Non-Votes     Not Applicable

3. The resolution to vote on the advisory vote on executive compensation was approved based on the following vote:

                       Votes For                25,123,416
                       Votes Withheld               34,445
                       Abstentions                       0
                       Broker Non-Votes     Not Applicable

4. The resolution to vote on the frequency of voting on executive compensation was approved for 1 Year based on the following vote:

                             1 Year       25,156,697
                             2 Years           1,111
                             3 Years              53
                             Withhold            588

5. The resolution to vote on the approval of the Corporation's stock option plan and the unallocated stock options thereunder was approved based on the following vote:

                              For         25,094,603
                              Against         63,798
                              Withold              0

Exhibit

10.23     Separation and Mutual Release Agreement by and between Adherex
          Technologies, Inc. and Dr. Thomas Spector

  Add ADHXF to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for ADHXF - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial      Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.